Pfizer’s Sutent fails in colon cancer, trial halted (Reuters)
Reuters – Pfizer Inc said a late stage trial testing its cancer drug Sutent in advanced colon cancer was discontinued after it was deemed to be no more effective than standard chemotherapy.